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The lung is one of the major sites of cathepsins (B, H, and L) expression where they are involved in 
several functions including degradation of extracellular matrix proteins, remodelling of the lung tissue 
and processing of the invariant chain of the MHC class II complex. Under pathological conditions, 
cathepsins have been observed in inflammation, tumour progression and metastasis. The enzymatic 
activity of cathepsins is regulated by changes in pH and their interaction with inhibitors. One of the 
potent and specific inhibitors of cathepsin L is the Cytotoxic T-lymphocyte antigen-2α (CTLA-2α) which 
was originally expressed in mouse activated T-cells and mast cells. However, the cellular localization 
and distribution pattern of CTLA-2α in the lung is not known. In this study, CTLA-2α expression in the 
lung was evaluated by immunofluorescence. Strong immunoreactivity was specifically detected in the 
bronchiolar epithelial cells of primary, secondary and terminal segments; moderate in the lymphoid 
nodules and scanty in the lung parenchyma. The distribution pattern implicates an important role of 
this inhibitor protein in relation to matrix remodelling, immune response and their relationship to lung 
development and diseases.  
 




The respiratory system evolved for efficient gas 
exchange with branching structures of trachea, 
bronchi, bronchioles and alveolar ducts that end 
as alveoli (Benkingsopp, 1967; Bowden, 1983). 
As opposed to trachea and bronchi, the 
bronchioles lack hyaline cartilage and they are 
divided into primary, secondary and tertiary or 
terminal bronchioles, which subdivide into two 
or more respiratory bronchioles and serve as 
regions of transition between conducting and 
respiratory portions of the respiratory system.  
 
The mucosa of the primary and secondary 
bronchioles is thrown into longitudinal folds that 
decrease in height towards the end of the 
secondary bronchioles. The epithelium is simple 
columnar but cuboidal in terminal and 
respiratory bronchioles. Openings of alveolar 
ducts occur in respiratory bronchioles and they 
end up into alveoli where gas exchange takes 
place (Becci, et al., 1978).   
 
The main cell types composing the bronchioles 
are ciliated cells, few microvillar cells, club cells 
(previously known as Clara cells) and clusters of 
neuroendocrine cells (DiAugustine and 
Sonstegard, 1984; Perl et al., 2005). The club 
cells secrete proteins, which serve as defence 
barrier and show anti-inflammatory, immune-
modulating and anti-tumorigenic roles in the 
lung (Yang, et al., 2004; Lee et al., 2006; 
Rawlins et al., 2009; Reynolds, et al., 2010). 
Following injury to mouse bronchioles, club 
cells act as progenitor cells for maintenance of 
the epithelium in the steady-state and 
regeneration of the injured bronchiolar 
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epithelium by differentiating into new ciliated 
cells (Hong, et al., 2001). Club cells are also 
reported to secrete a number of products 
including a surfactant which reduce surface 
tension that help to prevent collapse of the 
bronchioles; a cytochrome P-450 enzyme 
(CYP4B1) from smooth endoplasmic reticulum 
that detoxifies potentially harmful compounds 
in air (Stanley et al., 1992; Boei, et al., 2017); 
enzymes that break down mucus locally; 
molecules that participate in the transfer of IgA 
into the bronchiolar lumen and cytokines that 
regulate local inflammatory responses 
(Arsalane, et al., 2000; Singh and Katyal, 
2000). On the other hand, the neuroendocrine 
cells produce serotonin, calcitonin gene-related 
peptide and the mitogen bombesin. These 
bioactive substances have a role in the 
redistribution of pulmonary blood flow, 
regulation of bronchomotor tone, modulation of 
the immune response, stimulation of sensory 
nerve fibers and regulation of lung growth and 
development (Van Lommel, 2001).  
 
In the lung, cathepsins (B, H, and L) are also 
shown to participate in inflammatory responses, 
degradation of extracellular matrix proteins, 
remodeling and processing of secreted proteins 
and chain of the MHC class II complex (Bertini 
et al., 1981; Nakagawa et al., 1998; Shi et al., 
1999; Bühling, et al., 2004; Conus and Simon, 
2008). Cathepsin L differs from cathepsins B 
and H in its striking capacity to hydrolyze 
proteins (Katunuma and Kominami, 1983). 
Interestingly, the structure of CTLA-2α is 
homologous to the proregion of cathepsin L and 
that CTLA-2α is a potent and selective inhibitor 
of cathepsin L (Kurata et al. 2003). However, 
the cellular localization and distribution pattern 
of CTLA-2α in the lung is not known. The 
purpose of this study was therefore to examine 
by immunofluorescence the cellular localization 
and distribution pattern of CTLA-2α in the 
respiratory system. Such information is thought 
to be pertinent to several aspects of lung 





MATERIALS AND METHODS 
 
Tissue preparation 
All experiments conformed to the guidelines for 
animal use for experimentation of Sokoine 
University of Agriculture. Ten adult mice (five 
males and five females) were used in this 
study. The mice were deeply anesthetized with 
sodium pentobarbital (60mg/kg) by 
intraperitoneal injection. Transcardiac perfusion 
with 0.01M phosphate-buffered saline (PBS; pH 
7.4) was performed followed by 4% 
paraformaldehyde (PFA; Sigma-Aldrich, St. 
Louis, MO) in 0.1 phosphate buffer (PB; pH 
7.4). Lung tissues were dissected and postfixed 
in 4% PFA for 2 hours at 4oC followed by 
processing in ascending ethanol series to 
paraffin wax. Tissue blocks were cut at 4μm 
thick to produce serial tissue sections.  Some 
sections were used for Hematoxyline and Eosin 
staining and others for immunofluorescence 
labelling. 
 
Routine Hematoxyline and Eosin staining 
Tissue sections were deparaffinized in xylene 
followed by rehydration through a descending 
ethanol series to phosphate-buffered saline 
(0.01M PBS-pH7.4). The sections were stained 
using Hematoxylin-Eosin (H&E) in order to 
examine the normal structures of the lung.  
 
Antibody generation  
First, production of the recombinant protein of 
the CTLA-2α molecule with N-terminal poly-
histidine tag was performed followed by 
immunization of rabbit to obtain antiserum. 
Immunization and preparation of antiserum was 
performed as previously described (Takahashi 
et al., 1993). The polyclonal CTLA-2α antibody 
against CTLA-2α protein was obtained through 
affinity chromatography column with 
recombinant CTLA-2α conjugated resin. The 
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specificity of the purified antibody was 
characterized by Western blot as reported 
previously (Luziga et al., 2008)      
 
Immunofluorescence analysis  
Deparaffinazation of the tissues was performed 
as described in H&E staining.  Tissue sections 
were incubated for 30min at room temperature 
(RT) in 0.3%v/v hydrogen peroxide diluted in 
distilled water to inhibit endogenous peroxidase 
activity followed by washing (3x5 min) in PBS. 
Sections were then incubated with 10% goat 
normal serum for 30min at RT to block non-
specific binding, followed by incubation with the 
CTLA-2α antibody diluted at 1:500 in PBS, for 
24 hours in a dark, humid chamber at 4°C. For 
negative control, PBS was applied in place of 
CTLA-2α antibody. Sections were then washed 
(3X5min) in PBS followed by incubation with 
Alexa Fluor® 488-conjugated chicken anti-
rabbit IgG (FITC) at a dilution of 1:100 
(Molecular Probes) for 1hour at RT followed by 
washing the sections (3X5min) in PBS and 
mounting. Immunolabelling was analyzed using 






Routine histological examination findings 
The histological structure of the conducting 
airways and respiratory region were of normal 
morphological organization. Description is 
focused on bronchioles in which strong positive 
immunofluorescence labelling for CTLA-2α 
protein was observed. By H&E the bronchioles 
possessed primary, secondary and terminal or 
tertiary segments with mucosa being thrown 
into longitudinal folds that decreased in height 
towards the end of the secondary bronchioles. 
The epithelium was simple columnar in primary 
and secondary bronchioles but cuboidal in 
terminal and respiratory bronchioles. Goblet 
cells were few in all segments but hyaline 
cartilage was absent.  
 
 
Fig. 1:  Serial sections of primary bronchioles analysed by H&E and Immunofluorescence for CTLA-2α protein. The first 
row shows normal histological organization of bronchioles (A&C) and veins (E) stained with H&E. Note the folded 
epithelium (arrows) due to contraction of smooth muscles (sm) and lack of hyaline cartilage in the bronchioles; l, indicate 
lumen of bronchioles and ln, lymphatic nodules. The second row illustrates CTLA-2α expression in the primary bronchioles 
(B&D) detected by immunofluorescence. Strong immunolabelling is seen in the epithelium of the primary bronchioles 
(arrows). CTLA-2α expression is absent in the lung parenchyma and wall of veins (F); l indicates lumen of bronchioles; ln, 
lymphatic nodules and v, veins (Original magnification: X100). 
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Few smooth muscle cells surrounding the 
bronchioles were also evident, which in turn 
were surrounded by loose connective tissue. 
Alveolar ducts, alveolar sacs that ended in 
alveoli were also in normal histological 
organization. 
 
Immunofluorescence analysis  
To investigate the cellular localization and 
distribution pattern of CTLA-2α protein, 
immunofluorescence analysis was performed on 
the lung tissue sections. Highest level of CTLA-
2α labeling was detected within bronchiolar 
epithelial cells in the primary, secondary, 
terminal and respiratory segments. Moderate 
immunoreactivity was seen in the lymphoid 
nodules that are composed of immune cells. 
The lung parenchyma, blood vessels including 
arteries and veins were virtually devoid of 









Fig. 2: Immunofluorescence labelling for CTLA-2α in the primary bronchioles. Plates A, B, C, E & F show high level of 
CTLA-2α protein immunoreactivity in the epithelium of primary bronchioles (arrows). E &F are higher magnification to 
show the localization of CTLA-2α protein in the bronchiolar epithelial cells. Labelling is virtually absent in the control 
sections (D) incubated with the 10% PBS. l indicates lumen of the bronchioles and ln, lymphatic nodules (Original 
magnification: A, B, C & D X100; E&F X400).  
 









Fig. 4: Serial sections of terminal and respiratory bronchioles analysed by H&E and immunofluorescence for CTLA-
2α protein. The first row (A,C and E) shows normal structure of terminal or tertiary bronchiolar epithelium (arrows) 
stained with H&E. Note the folded epithelium with reduced lumen (l) and the associated blood vessels (solid arrow 
heads), presence of smooth muscles and lack of hyaline cartilage. The second row (B&D) shows 
immunofluorescence localization of CTLA-2α protein in the terminal bronchioles. High level of immunolabeling is 
seen in the epithelium (arrows) but not evident in the lung parenchyma. Note also positive immunoreactivity in the 
respiratory bronchioles (F) within the epithelial cells (solid arrow head). The respiratory bronchioles continue (rb) to 
alveolar duct (ad) which branch into alveolar sac   (Original magnification: A-F, X100). 
 
Fig. 3: Serial sections of secondary bronchioles and lung parenchyma analysed by H&E and immunofluorescence for 
CTLA-2α protein. The first row (A&C) demonstrates normal structures of secondary bronchioles with folded epithelium 
(arrows) and lack of hyaline cartilage and (E) normal lung parenchyma stained with H&E. Note the normal histological 
organization (E) of alveolar duct (ad) with branching continuity to alveolar sac (as) and alveoli (al); l indicates lumen of 
bronchioles; ln, lymphatic nodules and v, veins. The second row (B&D) shows secondary bronchioles and (F) lung 
parenchyma analyzed by immunofluorescence for CTLA-2α expression. Strong immunolabeling is seen in secondary 
bronchiolar epithelium (arrows), moderate in the lymphatic nodules (ln) but not evident in the lung parenchyma (F). 
(Original magnification: A-F, X100).  
 





The principal aims of this study were to 
investigate by immunofluorescence microscopy 
the cellular localization and distribution pattern 
of CTLA-2α in the adult mouse lung and deduce 
its functional implications in the respiratory 
system. Results obtained showed that CTLA-2α 
is highly expressed in the bronchiolar 
epithelium, moderate in the lymphatic nodules 
and virtually absent in the lung parenchyma. 
Whether the localization of CTLA-2α to 
bronchiolar epithelial cells is related to its role 
at least in part, to environmental components 
and its up‐regulation relationship to contact of 
epithelial cells with the extracorporeal space or 
processing bronchiolar surfactant or other 
bioactive molecules or modulation of cathepsins 
degradation or to a novel function, is a question 
that remains to be clarified.  
Studies show that the structure of CTLA-2α 
protein is highly homologous to the proregion 
of cathepsins. The propeptide of the proregion 
is part of the enzyme but CTLA-2α is a protein 
expressed independently and it is designated as 
a member of I29 protease inhibitor family 
(MEROPS peptidase database number I29.002 
(http://merops.sanger.ac.uk/). CTLA-2α is also 
shown to exhibit potent and selective inhibition 
to mouse cathepsin L (Kurata et al. 2003). 
Although the functional implications underlying 
the localization of CTLA-2α protein in the 
bronchioles is unclear, in light of these, it is 
reasonable to conclude that through regulation 
of cathepsin activity, CTLA-2α in the lung 
participate in inflammatory responses, 
degradation of extracellular matrix proteins, 
remodelling and processing of secreted 
proteins. Indeed, simultaneous localization of 
cathepsin L and CTLA-2α proteins in various 
regions of the mouse brain has been 
demonstrated by immunofluorescence analysis 
(Luziga, et al., 2016), suggesting that the 
turnover of CTLA-2α and cathepsin L is 
regulated independently possibly through 
posttranslational regulation that allows 
immediate and selective changes in the protein 
levels in the bronchiolar epithelium. 
 
One of the cell types composing the bronchiolar 
epithelium are neuroendocrine and club cells 
(DiAugustine and Sonstegard, 1984; Perl et al., 
2005). Neuroendocrine cells produce serotonin, 
calcitonin gene-related peptide and the mitogen 
bombes that have a role in stimulation of 
sensory nerve fibers and regulation of lung 
growth and development (Van Lommel, 2001). 
Nerve fibers are also remarkable for their high 
concentration of CTLA-2α protein (Luziga, et 
al., 2008, 2016). On the other hand, club cells 
secrete proteins such as Scgb1a1/CCSP/CC10, 
which serve as a defence barrier and show anti-
inflammatory, immune-modulating and anti-
tumorigenic roles in the lung (Yang, et al., 
2004; Lee et al., 2006; Reynolds, et al., 2010). 
The cells also secrete other products such as 
surfactant which reduce surface tension in 
order to maintain bronchiolar patency and 
cytochrome P-450 enzyme (CYP4B1) that 
detoxifies potentially harmful compounds in air 
(Stanley, et al., 1992|, Boei, et al., 2017). 
Taking altogether, the localization of CTLA-2α 
at high levels in the bronchiolar epithelium is 
suggestive of its participation in the processing 
of bronchiolar surfactant and other enzymes or 
possibly involved in some other novel biological 
functions that are yet to be identified.    
 
In conclusion, this study demonstrates that the 
expression of CTLA-2α protein in the adult 
mouse lung is mainly localized in bronchiolar 
epithelial cells. This finding is suggestive of an 
important function of CTLA-2α in relation to 
matrix remodeling, immune response and their 
relationship to lung diseases. This report is 
thought to be a helpful tool for understanding 
CTLA-2α and opens the way to new studies on 
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